China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Significant Decline in Short Interest

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the target of a large decline in short interest in March. As of March 15th, there was short interest totalling 32,900 shares, a decline of 54.8% from the February 28th total of 72,800 shares. Approximately 0.2% of the shares of the stock are short sold. Based on an average trading volume of 127,900 shares, the short-interest ratio is currently 0.3 days.

China SXT Pharmaceuticals Price Performance

NASDAQ SXTC opened at $2.75 on Friday. China SXT Pharmaceuticals has a twelve month low of $2.40 and a twelve month high of $26.96. The company’s 50-day simple moving average is $3.43 and its 200 day simple moving average is $3.86.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.